source
- Supreme Court hints at ruling in case over generics' use of skinny-label drugsSupreme Court justices have offered preliminary signals about how they may decide a contentious lawsuit that could reshape the way generic drug makers market products with "skinny labels". The cas…
- Avalyn Pharma launches $300M IPO, selling 16.5 million shares at $18 eachAvalyn Pharma, a Boston-based biotech, announced an initial public offering that aims to raise roughly $300 million. The company will sell more than 16.5 million shares at $18 per share and is set…